BRIANSTORM - Early Identification of Patients With Brain Metastases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-08-16

Study Completion Date

2025-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A single arm observational study investigating the incidence of brain metastasis in patients with cancer recti and lung metastasis

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Humoral and Tumoral Molecular Alteration Profile of Brain Metastases

NCT05848050

Brain Metastases

COMPLETED NA

Improved Assessment of Response in Metastatic Renal Cell Carcinoma Using Spectral-CT

NCT03616951

Renal Neoplasm With Metastasis Response Evaluation Criteria in Solid Tumors

UNKNOWN

Genetic Analysis of Brain Tumors

NCT00031538

Glioma Glioblastoma Multiforme Anaplastic Astrocytoma +2 more

TERMINATED

Leveraging ctDNA Analysis to Improve Early Detection of Cancer Recurrence in the High-Risk Melanoma Setting

NCT05079113

Stage III Melanoma Stage IV Cutaneous Melanoma

COMPLETED

Natural History Study of Children and Adults With Adrenocortical Cancer (ACC)

NCT04447014

Adrenocortical Carcinoma Adrenocortical Cancer

TERMINATED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In this study the investigators want to investigate the incidence of brain metastasis in a selected high-risk group of patients with metastatic colorectal cancer. Possible prognostic biological aspects will be investigated by translational analysis of biological samples. The study population consists of patients with metastatic rectal cancer and presence of lung metastasis. The patients will undergo a standard MRI scan of the brain including injection of intravenous contrast. If positive finding, images will be evaluated at the multidisciplinary tumor board for potential treatment options according to clinical practice. Standard follow-up program is followed, as per clinical practice. If the initial MRI scan of cerebrum detects brain metastasis this will be treated and followed as per clinical practice. Translational blood samples will be drawn at inclusion and at every imaging schedule up til 5 times

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metastatic Rectal Adenocarcinoma Brain Metastases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Primary rectal tumor location

* Diagnosis of lung metastasis made by histo- or cytopathology, or by clinical and imaging criteria.
* Able to understand written information
* Consent to samples for translational research